首页> 外文学位 >Genome Engineering Technology and Its Application in Mammalian Cells.
【24h】

Genome Engineering Technology and Its Application in Mammalian Cells.

机译:基因组工程技术及其在哺乳动物细胞中的应用。

获取原文
获取原文并翻译 | 示例

摘要

The advancement of high-throughput, large-scale biochemical, biophysical, and genetic technologies has enabled the generation of massive amounts of biological data and allowed us to synthesize various types of biomaterial for engineering purposes. This enabled improved observational methodologies for us to navigate and locate, with unprecedented resolution, the potential factors and connections that may contribute to biological and biomedical processes. Nonetheless, it leaves us with the increasing demand to validate these observations to elucidate the actual causal mechanisms in biology and medicine. Due to the lack of powerful and precise tools to manipulate biological systems in mammalian cells, these efforts have not been able to progress at an adequate pace.;This work aims to bridge the gap between data generation and experimental verification by developing molecular-resolution genome engineering technologies that can effect cell-specific genetic and epigenetic perturbation in mammalian cells. The development of these novel tools starts from harnessing aspects of two prominent families of microbial systems, the Transcription Activator-like Effectors (TALEs) and the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas systems. The development of these technologies was executed through several lines of engineering efforts. When applied in higher eukaryotes, these tools provide researchers with new reverse engineering instruments to directly probe relevant biological molecules and pathways that are observed from analysis of biological data. In combination with sensitive and accurate readout methods in mammalian systems, these technologies could together establish transformative means for modeling the causal relationships between genetic or epigenetic variances and human disease, while also serving as the first step towards the development of rational molecular therapies for complex human disorders and of synthetic biology applications for the research community.
机译:高通量,大规模生化,生物物理和遗传技术的发展使得能够生成大量的生物数据,并使我们能够为工程目的合成各种类型的生物材料。这使我们能够改进观测方法,以前所未有的分辨率浏览和定位可能对生物学和生物医学过程产生影响的潜在因素和联系。但是,这使我们越来越需要验证这些观察结果,以阐明生物学和医学中的实际因果机制。由于缺乏强大而精确的工具来操纵哺乳动物细胞中的生物系统,因此这些努力未能以适当的速度进行。;这项工作旨在通过开发分子分辨率基因组来弥合数据生成和实验验证之间的鸿沟可以影响哺乳动物细胞中特定于细胞的遗传和表观遗传扰动的工程技术。这些新颖工具的开发从利用两个著名的微生物系统家族(转录激活因子样效应物(TALE)和成簇的规则间隔的短回文重复序列(CRISPR)/ Cas系统)开始。这些技术的开发是通过几项工程努力来执行的。当应用于高级真核生物时,这些工具为研究人员提供了新的逆向工程工具,可直接探测从生物学数据分析中观察到的相关生物分子和途径。结合哺乳动物系统中灵敏而准确的读出方法,这些技术可以共同建立用于模拟遗传或表观遗传变异与人类疾病之间因果关系的转化手段,同时也为开发针对复杂人类的合理分子疗法提供了第一步疾病和合成生物学在研究界的应用。

著录项

  • 作者

    Cong, Le.;

  • 作者单位

    Harvard University.;

  • 授予单位 Harvard University.;
  • 学科 Biology Molecular.;Biology Genetics.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 205 p.
  • 总页数 205
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号